These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23985877)

  • 1. Apparent treatment-resistant hypertension among elderly Korean hypertensives: an insight from the HIT registry.
    Choi SW; Kim MK; Han SW; Han SH; Lee BK; Lee SU; Hur SH; Lim SW; Moon KW; Lee SG; Lee SH; Oh SK; Chea JG; Joo SJ; Jo MC; Hong KS; Ryu KH;
    J Hum Hypertens; 2014 Mar; 28(3):201-5. PubMed ID: 23985877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hypertension subtypes and treatment outcome among elderly Korean hypertensives.
    Choi SW; Kim MK; Han SW; Kim SH; Kim HJ; Kang SM; Kim DK; Kim BS; Kim WH; Kim JY; Kim HY; Rhew JY; Park KS; Cho KI; Jeong MH; Jeong YS; Ryu KH;
    J Am Soc Hypertens; 2014 Apr; 8(4):246-53. PubMed ID: 24568934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel.
    Weitzman D; Chodick G; Shalev V; Grossman C; Grossman E
    Hypertension; 2014 Sep; 64(3):501-7. PubMed ID: 24958503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study.
    Lithovius R; Harjutsalo V; Mutter S; Gordin D; Forsblom C; Groop PH;
    Diabetes Care; 2020 Aug; 43(8):1885-1892. PubMed ID: 32444456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetes.
    Yokoyama H; Araki S; Watanabe S; Honjo J; Okizaki S; Yamada D; Shudo R; Shimizu H; Sone H; Haneda M
    Diabetes Res Clin Pract; 2015 Oct; 110(1):18-25. PubMed ID: 26361860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry.
    Kim HJ; Shin JH; Lee Y; Kim JH; Hwang SH; Kim WS; Park S; Rhee SJ; Lee EM; Ihm SH; Pyun WB; Shin J
    Korean J Intern Med; 2021 Sep; 36(5):1102-1114. PubMed ID: 34134467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey.
    Zheng Y; Tang L; Chen X; Cai G; Li W; Ni Z; Shi W; Ding X; Lin H
    Clin Exp Hypertens; 2018; 40(8):784-791. PubMed ID: 29509105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-blood pressure monitoring is associated with improved awareness, adherence, and attainment of target blood pressure goals: Prospective observational study of 7751 patients.
    Jo SH; Kim SA; Park KH; Kim HS; Han SJ; Park WJ
    J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1298-1304. PubMed ID: 31393062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting.
    Kim YS; Kim HS; Oh HY; Lee MK; Kim CH; Kim YS; Wu D; Johnson-Levonas AO; Oh BH
    Hypertens Res; 2013 Sep; 36(9):807-23. PubMed ID: 23698804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of blood pressure control in patients with resistant hypertension.
    Pales J; Kamensky G; Payer J
    Bratisl Lek Listy; 2016; 117(10):571-576. PubMed ID: 27826971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study.
    Jo I; Ahn Y; Lee J; Shin KR; Lee HK; Shin C
    J Hypertens; 2001 Sep; 19(9):1523-32. PubMed ID: 11564970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is resistant hypertension really resistant?
    Brown MA; Buddle ML; Martin A
    Am J Hypertens; 2001 Dec; 14(12):1263-9. PubMed ID: 11775136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study).
    Jung HW; Kim KI; Park CG; Kang DH; Ahn Y; Bae JH; Kim CH
    Clin Exp Hypertens; 2015; 37(6):482-9. PubMed ID: 25816197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.
    Haddadin F; Sud K; Munoz Estrella A; Moctezuma S; Wu L; Berookhim J; Lucas CH; Patel D; Argulian E
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1507-1515. PubMed ID: 31448866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.
    Barochiner J; Alfie J; Aparicio LS; Cuffaro PE; Rada MA; Morales MS; Galarza CR; Waisman GD
    Clin Exp Hypertens; 2013; 35(6):412-7. PubMed ID: 23148480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.